Publication | Open Access
Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis
246
Citations
19
References
2004
Year
Rituximab appears to be a safe and effective therapeutic option in symptomatic patients with HCV-associated MC glomerulonephritis and signs of systemic vasculitis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1